A MIPS score for wound care is a 0 to 100 composite built from four performance categories, and for many wound clinicians the hard part is the Quality category, where the standard measure menu was designed for other specialties. A clinician who treats six-month-old wounds in patients with diabetes, venous disease, and peripheral artery disease can be scored against measures that ignore all of that. This article explains how the final score is assembled, where generic measures work against wound care, and how a QCDR with risk-adjusted wound measures changes the result.
How Is a MIPS Score Calculated for Wound Care Clinicians?
The Merit-based Incentive Payment System scores eligible clinicians on four categories: Quality, Cost, Promoting Interoperability, and Improvement Activities. Each category produces its own score, CMS multiplies each by its weight, and the sum becomes a final score from 0 to 100. That final score determines a payment adjustment applied to Medicare Part B payments two years later.
For the 2026 performance year, Quality counts for 30 percent, Cost for 30 percent, Promoting Interoperability for 25 percent, and Improvement Activities for 15 percent, the same weights CMS has used in recent years. CMS finalized its 2026 MIPS policies in the CY 2026 Physician Fee Schedule final rule, and the CMS Quality Payment Program site has the details. Cost is calculated by CMS from claims, so you do not submit it. When a category does not apply to a clinician, CMS can reweight its points to the other categories.
The payment adjustment depends on where your final score lands against the performance threshold. CMS has set the threshold at 75 points and will hold it there through the 2028 performance year. Scoring below it brings a negative adjustment of up to 9 percent, and scoring above it brings a positive one. Positive adjustments are scaled to keep the program budget neutral, so they are far smaller in practice: based on 2024 scores, the maximum positive adjustment for 2026 payments was about 1.05 percent, while the penalty side kept its full 9 percent. Dr. Caroline Fife has written about what she would fix about MIPS.
An illustrative calculation
Suppose a podiatry practice earns the following category scores. These numbers are hypothetical and chosen only to show the arithmetic, and they assume the 30/30/25/15 weights above.
- Quality: 70 out of 100, contributing 21 points
- Cost: 60 out of 100, contributing 18 points
- Promoting Interoperability: 100 out of 100, contributing 25 points
- Improvement Activities: 100 out of 100, contributing 15 points
The final score is 79, above a 75-point threshold. If Quality had come in at 40 instead, the practice would lose 9 points and land at 70, below the threshold. Quality is the category most within your control, and it is the one most sensitive to which measures you report.
Why Do Standard MIPS Measures Fit Wound Care Poorly?
Consider the typical patient in a wound center. The wound is chronic, often months old. The patient frequently has diabetes, venous insufficiency, or PAD, plus renal disease, obesity, neuropathy, or limited mobility. Many of these factors affect whether and how fast a wound heals regardless of how good the care is.
Most traditional MIPS quality measures do not account for any of that. A measure that compares raw outcomes between clinicians implicitly assumes patients are comparable. In wound care they are not. A clinician who accepts referrals for the hardest cases, such as long-standing ulcers, ischemic limbs, and patients with poor offloading adherence, will look worse than one who treats mostly superficial, recent wounds, even if the first clinician delivers better care.
Two structural problems compound this:
- Few specialty-specific options. The traditional MIPS measure set has limited measures written for chronic wound management, so clinicians are steered toward generic measures such as tobacco screening or medication documentation that say little about wound outcomes.
- Topped-out measures. When nearly everyone performs well on a measure, CMS designates it topped out and caps the points available, which limits how much it can lift your Quality score. Generic process measures are common candidates. Check the current benchmark files published on the CMS QPP site to see which measures are topped out for the 2026 performance year.
The result is a measure choice between relevant but poorly adjusted outcomes and irrelevant but easy process measures with low scoring ceilings. Neither reflects what a wound clinician actually does.
This also feeds a common misconception: that a low raw healing rate means poor care. It may only mean a difficult case mix. Without adjustment, the number cannot tell the two apart.
What Is a QCDR and How Does It Change Your Wound Care MIPS Score?
A Qualified Clinical Data Registry, or QCDR, is a CMS-approved entity that collects clinical data from participating clinicians and submits it to MIPS on their behalf. It differs from a qualified registry, which reports measures from CMS’s existing menu, and from EHR-only reporting, which is limited to the measures your EHR vendor has certified. A QCDR can also submit its own measures.
That last point is what matters for wound care. QCDRs develop and self-nominate measures, and CMS reviews and approves them each year. A QCDR focused on a specialty can therefore offer measures built around that specialty’s patients, including outcome measures with risk adjustment. Approval status can change from year to year, so confirm that the measures you plan to use are approved for the current performance year.
This also corrects another misconception. Not every registry satisfies MIPS the same way. A general registry limited to CMS’s standard measures gives you the same menu you already have, while a specialty QCDR changes what you can be measured on.
How USWR fits in
US Wound & Podiatry Registries (USWR) has operated as a QCDR for wound care and podiatry since 2014. It collects structured clinical data from participating practices and reports MIPS measures through the registry. It works in partnership with the Alliance of Wound Care Stakeholders, which brings clinical societies and other stakeholders together around wound care policy. For the specific measures available this year, including their names, numerators, and risk adjustment specifications, use the current measure list on the USWR website rather than relying on a summary, since QCDR measure sets are revised annually.
Practically, joining a QCDR means choosing measures that describe your patients, submitting through one channel, and receiving feedback on performance that is comparable to peers treating similar cases. The sections below cover why the risk adjustment piece matters and how to implement it.
What Does Risk Adjustment Mean for Wound Healing Outcomes?
Risk adjustment compares the outcomes you observed with the outcomes expected given your patients’ characteristics. If your patients were sicker or their wounds harder, the expected healing rate is lower, and your performance is judged against that lower expectation. The question changes from “how many wounds healed?” to “how did results compare with what we would predict for these patients?”
Variables commonly used in wound outcome models include wound size, wound duration, wound etiology (diabetic foot ulcer, venous leg ulcer, pressure injury, arterial), and patient comorbidities such as diabetes control, vascular status, and renal disease. USWR’s risk-stratified healing measures for diabetic foot ulcers and venous leg ulcers are built on this approach, as Dr. Caroline Fife and colleagues have described. The exact variable set differs by measure, so check the specification for each USWR measure you intend to report.
An illustration of why it matters
Imagine two clinics that both report a 50 percent healing rate over the same period. These figures are hypothetical. Clinic A mostly treats wounds under three months old in patients with controlled diabetes. Clinic B receives referrals for large, long-standing ulcers in patients with PAD and chronic kidney disease. Raw rates say the clinics are equal. After adjustment, Clinic A may be performing below expectation, because its patients were likely to heal more often, while Clinic B may be performing above it. Same raw number, opposite conclusions.
For clinicians, this protects against being penalized for accepting complex referrals. For administrators, it is a matter of credibility. A quality VP or CMO comparing sites or clinicians across a roster needs scores that hold up when someone asks, “Is that site worse, or are its patients sicker?” Unadjusted figures invite that challenge and often lose. Adjusted figures give you an answer built on documented case mix.
Risk adjustment does not excuse poor results. It sets a fairer reference point, and it can reveal real underperformance that a favorable case mix would otherwise hide.
How Can Wound Care Practices Raise a MIPS Score Without Double Data Entry?
Most of the work is in setup. Once measures and data capture are configured, reporting should draw from documentation clinicians already complete.
- Select measures. Choose measures that fit your patient population and have scoring potential, meaning they are not topped out and have benchmarks. Aim for a Quality submission that includes at least one outcome measure.
- Confirm eligibility and pathway. Determine whether each clinician is MIPS eligible and whether you will report individually, as a group, or through an APM. Check low-volume threshold and small-practice rules for 2026 on qpp.cms.gov; Dr. Caroline Fife’s guide to understanding your QPP status walks through the lookup.
- Set up EHR data capture. Map the data elements each measure needs to structured fields in your EHR, so values such as wound dimensions, etiology, and healing status are recorded once, in discrete form.
- Submit through the QCDR. The registry transmits the data to CMS. Confirm the 2026 submission window with CMS, since CMS has historically opened submission in the first quarter after the performance year ends.
Duplicate entry is avoided at step three. Ask the registry directly which EHR integrations are supported and how data is transferred, and verify specifics before assuming a connection exists for your system. EHR-only reporting is also not enough on its own if your EHR lacks measures relevant to wound care.
Mistakes that cost points
- Choosing measures by ease. Easy measures often have low ceilings or are topped out.
- Missing data completeness. Measures generally must be reported on a minimum share of eligible patients, and falling short can reduce or zero out the measure’s score. Check the current requirement.
- Reporting a partial year. A late start leaves less data and weakens performance estimates.
- Ignoring the other categories. Promoting Interoperability and Improvement Activities together carry 40 percent of the score under the 2026 weights, and they are often the most straightforward points to earn.
What Does Registry Data Add Beyond the MIPS Score?
The same structured data that supports MIPS reporting has a second use. Randomized trials in wound care often exclude patients with multiple comorbidities, large wounds, or long wound duration, which are the patients seen in everyday practice. Coverage policy for cellular and tissue-based products, negative pressure wound therapy, and hyperbaric oxygen then rests on evidence from populations that do not look like the people being treated. A registry captures real-world outcomes in the patients trials leave out, with the case-mix detail needed to interpret them.
That evidence has had policy consequences. When the RUC revalued physician supervision of hyperbaric oxygen therapy, USWR registry data on patient complexity and supervision workload informed the analysis, documenting that the typical patient had about 10 comorbidities and 12 medications. The supervision payment was still reduced, and the authors concluded that thin registry participation leaves clinicians without the data needed to counter future challenges to reimbursement. Dr. Caroline Fife has also tracked trends in physician supervision of HBOT.
Different readers use registry data differently:
- Medical directors benchmark their center against comparable peers and identify where outcomes diverge from expectation.
- Researchers can study real-world effectiveness questions in a field with limited funding for large trials.
- Product manufacturers use de-identified data for real-world evidence, post-market studies, and discussions with payers about coverage.
USWR also publishes white papers on wound care research, which are a useful starting point for seeing how the data is analyzed and reported.
A Defensible Wound Care MIPS Score Starts With the Measure Set
The arithmetic of MIPS is the same for everyone, but the inputs are not. A wound care score is only defensible when its measures account for patient complexity, because otherwise the number reflects case mix as much as care quality. Risk-adjusted, specialty-specific measures submitted through a QCDR are the most direct way to close that gap.
Start by listing the Quality measures you currently report and checking each against the CMS benchmark files for topped-out status and scoring potential. Then compare that list with the measures a wound-focused QCDR offers for 2026, and ask any registry you evaluate which EHR connections it supports. Learn more about our services
Recent Comments